Title
Category
Credits
Event date
Cost
Episode 2: Update on Rapid-Onset Therapies for Major Depressive Disorder
  • Depression
  • Major Depressive Disorder
  • Women’s Mental Health
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
$0.00
The new fast-acting antidepressants esketamine, an NMDA receptor antagonist, and positive allosteric modulators of GABAergic neurotransmission brexanolone and zuranolone have created an important and exciting paradigm shift in the treatment of depression.
Tweetorial: A Rationale for Treating CKD with Combination Therapy
  • Renal Disease
  • Cardiology
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Participation
$0.00
Clinicians have a number of therapeutic agents to choose from when treating T2D at risk of CKD. However, it's important to know how to sequence these therapies in real-world practice.
Tweetorial: CKD in Real-World Practice: Examine a Patient Case
  • Renal Disease
  • Cardiology
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Participation
$0.00
Experts examine a patient case study as a way of translating guideline-based screening recommendations and current therapies that protect T2D patients from CKD progression in real-world practice.
Therapeutic Advances for Epileptic Seizure Rescue
  • Epilepsy
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
$0.00
Neurologists and other clinicians can improve care by identifying individuals who are susceptible to seizure clusters and educating them on rescue therapies and medications.
Tweetorial: Parkinson’s Disease Psychosis: Best Practices for Diagnosing PDP
  • Parkinson Disease
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Participation
$0.00
Parkinson’s disease psychosis (PDP) is a nonmotor symptom of Parkinson’s disease (PD) and includes at least 1 symptom of hallucinations, illusions, delusions, or false sense of presence after onset of PD and recurrent/continuous for 1 month or more.
Parkinson's Disease Psychosis: Review of Neuropsychiatric Complications
  • Parkinson Disease
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
$0.00
An average of 35% of patients diagnosed with Parkinson’s disease experience Parkinson’s psychosis. Recognition and diagnosis of this nonmotor manifestation is critical in choosing the best treatment strategy and managing these symptoms.
Seizure Clusters in the Real World: The Call to Arms
  • Epilepsy
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
$0.00
Treatment standards for neurologists and other clinicians caring for patients with epilepsy with emphasis on understanding epilepsy epidemiology, SUDEP and ILAE Classification updates, and therapeutic strategies.
Improving Clinician Awareness of Rett Syndrome and Optimizing Management of Care Across the Patient Lifespan
  • Rett Syndrome
  • Child and Adolescent Psychiatry
  • Movement Disorders
  • Neurology
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
Because of the multiple comorbidities associated with Rett syndrome, clinicians are advised to incorporate clinical guidelines that suggest implementing therapeutics with a multidisciplinary approach and with an eye toward new and emerging therapies. 
An Individualized Approach to PAH Therapy Based on Clinical Data, Goal-Directed Therapy, and Risk Stratification 
  • Cardiology
  • Comorbidity
  • Education
  • Integrated Care
  • Medical Conditions
  • Pulmonary Disease
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
Pulmonary arterial hypertension requires risk stratification to develop goal-directed treatment plans, including combination therapy targeting multiple pathways.
Translating Clinical Trial Data into Real-World Practice: Examining CKD Screening and Three Patient Case Profiles
  • Renal Disease
  • Adherence
  • Cardiology
  • Comorbidity
  • Diagnostic Tools
  • Education
  • Medical Conditions
  • Primary Care
  • Side Effects
  • Weight
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
Regular screening of UACR and adding finerenone to SGLT2 inhibitors can greatly impact T2D at risk for CKD. Join faculty as they discuss three patient cases.

Pages